These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1024 related items for PubMed ID: 22994348

  • 1. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V, Batard T, Nguyen H, Fréreux M, Horiot S, Harwanegg C, Bergmann KC, de Beaumont O, Moingeon P.
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [Abstract] [Full Text] [Related]

  • 2. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH, Chen L, Cheng L, Li KN, Yuan H, Lu JH, Li H.
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [Abstract] [Full Text] [Related]

  • 3. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT, Iraola V, Himly M, Robinson DS, Badiola C, García-Robaina JC, Briza P, Carnés J.
    Int Arch Allergy Immunol; 2010 Jun; 153(1):61-9. PubMed ID: 20357486
    [Abstract] [Full Text] [Related]

  • 4. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
    Tseng SH, Fu LS, Nong BR, Weng JD, Shyur SD.
    Asian Pac J Allergy Immunol; 2008 Jun; 26(2-3):105-12. PubMed ID: 19054928
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC, Demoly P, Worm M, Fokkens WJ, Carrillo T, Tabar AI, Nguyen H, Montagut A, Zeldin RK.
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [Abstract] [Full Text] [Related]

  • 6. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [Abstract] [Full Text] [Related]

  • 7. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 8. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E.
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L, Wang J, Chen Y, Luo R, Tao J, Nie M, Liu B, Li Y.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK, Chen WY, Huang JL, Lue KH, Wang JY.
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [Abstract] [Full Text] [Related]

  • 11. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE, Choi YS, Kim MS, Han DH, Rhee CS, Lee CH, Kim DY.
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [Abstract] [Full Text] [Related]

  • 13. House dust mite sublingual immunotherapy: results of a US trial.
    Bush RK, Swenson C, Fahlberg B, Evans MD, Esch R, Morris M, Busse WW.
    J Allergy Clin Immunol; 2011 Apr; 127(4):974-81.e1-7. PubMed ID: 21333346
    [Abstract] [Full Text] [Related]

  • 14. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy.
    Bronnert M, Mancini J, Birnbaum J, Agabriel C, Liabeuf V, Porri F, Cleach I, Fabre A, Deneux I, Grandné V, Grob JJ, Berbis P, Charpin D, Bongrand P, Vitte J.
    Clin Exp Allergy; 2012 Sep; 42(9):1406-15). PubMed ID: 22747483
    [Abstract] [Full Text] [Related]

  • 15. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM, Moed H, Berger MY, Röder E, de Groot H, de Jongste JC, van Wijk RG, van der Wouden JC.
    BMC Fam Pract; 2008 Oct 20; 9():59. PubMed ID: 18937864
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN, Barlan IB.
    Clin Exp Allergy; 2010 Jun 20; 40(6):922-32. PubMed ID: 20100188
    [Abstract] [Full Text] [Related]

  • 17. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C, Mayorga C, Corzo JL, Jurado A, Torres MJ.
    Pediatr Allergy Immunol; 2008 May 20; 19(3):210-8. PubMed ID: 18399897
    [Abstract] [Full Text] [Related]

  • 18. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB.
    Int Arch Allergy Immunol; 2012 May 20; 157(3):288-98. PubMed ID: 22041501
    [Abstract] [Full Text] [Related]

  • 19. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care.
    de Bot CM, Moed H, Berger MY, Röder E, Hop WC, de Groot H, de Jongste JC, van Wijk RG, Bindels PJ, van der Wouden JC.
    Pediatr Allergy Immunol; 2012 Mar 20; 23(2):150-8. PubMed ID: 22017365
    [Abstract] [Full Text] [Related]

  • 20. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
    Kim ST, Han DH, Moon IJ, Lee CH, Min YG, Rhee CS.
    Am J Rhinol Allergy; 2010 Mar 20; 24(4):271-5. PubMed ID: 20819465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.